Dan-Victor Giurgiutiu
Research Subjects
Dan-Victor Giurgiutiu has a total of 1000 co-authors. Here are the top co-authors by number of shared publications:
- Seena Dehkharghani
Department of Radiology, Neuroradiology Division Stanford University Stanford California USA
5 shared publications Albert J Yoo
4 shared publications- Xabier Urra
Department of Neurology, Hospital Clinic de Barcelona, Barcelona, Spain
4 shared publications A Aceituno
3 shared publicationsA Adams
3 shared publicationsA Aghaebrahim
3 shared publications
Latest Publications
- Open Access
- 1 September 2026
- Published by Wolters Kluwer Health in Stroke: Vascular and Interventional Neurology
- Vol. 6 (5) , e002185
Computed Tomography–Based Imaging Scores in Basilar Artery Occlusions: A Comparison of Predictive Abilities for Functional Outcomes
BACKGROUND: Posterior circulation large-vessel occlusion strokes have significant morbidity and mortality, but patient selection for acute interventions remains understudied. Multiple computed tomography (CT)–based scores exist, including the CT perfusion–based critical area perfusion score (CAPS), CT angiography–based basilar artery treatment management and posterior circulation CT angiography scores, and CT angiography source image or noncontrast CT–based posterior circulation Alberta Stroke Program Early CT Score, but their predictive values for long-term outcomes after thrombectomy have not been directly compared. METHODS: We conducted a retrospective multicenter cohort study of patients with basilar artery occlusions treated with endovascular thrombectomy. Four CT-based scores were assessed: posterior circulation Alberta Stroke Program Early CT Score, basilar artery treatment management score, posterior circulation CT angiography score, and CAPS. The primary outcome of interest for the study was a favorable functional outcome at 3 months (modified Rankin Scale score, 0–3). We calculated sensitivity, specificity, positive and negative predictive values, and generated receiver operating characteristic curves measuring area under the curve (AUC), which were compared with nonparametric methods. RESULTS: Ninety-eight patients were included for analysis, with an average age of 64.9 ± 15.6 years. The median National Institutes of Health Stroke Scale score was 13.5 (interquartile range, 7.0–23.0). AUC values were highest for the CAPS (AUC, 0.72 [95% CI, 0.63–82]) and lowest for the posterior circulation CT angiography score (AUC, 0.57 [95% CI, 0.45–0.68]; P =0.019). There was a trend toward the CAPS outperforming the basilar artery treatment management score (AUC, 0.66 [95% CI, 0.55–0.77]) and posterior circulation Alberta Stroke Program Early CT Score (AUC, 0.63 [95% CI, 0.52–0.75]) though this was not statistically significant ( P =0.29 and P =0.23, respectively). CAPS ≤3 demonstrated 100% sensitivity and negative predictive value (95% CI, 92.6–100.0%; 95% CI, 75.7–100.0%, respectively) for good outcome but had low specificity (24.0% [95% CI, 14.3–37.4]). CONCLUSIONS: The CT perfusion–based CAPS had the best performance for predicting good functional outcome at 3 months and had high sensitivity and negative predictive values though our finding is limited by the small number of patients who had CAPS >3. The CAPS should be validated in prospective studies.
- 1 September 2026
- Published by Wolters Kluwer Health in Stroke: Vascular and Interventional Neurology
- Vol. 6 (5) , e002185
Open AccessComputed Tomography–Based Imaging Scores in Basilar Artery Occlusions: A Comparison of Predictive Abilities for Functional Outcomes
BACKGROUND: Posterior circulation large-vessel occlusion strokes have significant morbidity and mortality, but patient selection for acute interventions remains understudied. Multiple computed tomography (CT)–based scores exist, including the CT perfusion–based critical area perfusion score (CAPS), CT angiography–based basilar artery treatment management and posterior circulation CT angiography scores, and CT angiography source image or noncontrast CT–based posterior circulation Alberta Stroke Program Early CT Score, but their predictive values for long-term outcomes after thrombectomy have not been directly compared. METHODS: We conducted a retrospective multicenter cohort study of patients with basilar artery occlusions treated with endovascular thrombectomy. Four CT-based scores were assessed: posterior circulation Alberta Stroke Program Early CT Score, basilar artery treatment management score, posterior circulation CT angiography score, and CAPS. The primary outcome of interest for the study was a favorable functional outcome at 3 months (modified Rankin Scale score, 0–3). We calculated sensitivity, specificity, positive and negative predictive values, and generated receiver operating characteristic curves measuring area under the curve (AUC), which were compared with nonparametric methods. RESULTS: Ninety-eight patients were included for analysis, with an average age of 64.9 ± 15.6 years. The median National Institutes of Health Stroke Scale score was 13.5 (interquartile range, 7.0–23.0). AUC values were highest for the CAPS (AUC, 0.72 [95% CI, 0.63–82]) and lowest for the posterior circulation CT angiography score (AUC, 0.57 [95% CI, 0.45–0.68]; P =0.019). There was a trend toward the CAPS outperforming the basilar artery treatment management score (AUC, 0.66 [95% CI, 0.55–0.77]) and posterior circulation Alberta Stroke Program Early CT Score (AUC, 0.63 [95% CI, 0.52–0.75]) though this was not statistically significant ( P =0.29 and P =0.23, respectively). CAPS ≤3 demonstrated 100% sensitivity and negative predictive value (95% CI, 92.6–100.0%; 95% CI, 75.7–100.0%, respectively) for good outcome but had low specificity (24.0% [95% CI, 14.3–37.4]). CONCLUSIONS: The CT perfusion–based CAPS had the best performance for predicting good functional outcome at 3 months and had high sensitivity and negative predictive values though our finding is limited by the small number of patients who had CAPS >3. The CAPS should be validated in prospective studies.
- Open Access
- 1 January 2026
- Published by Wiley in Case Reports in Neurological Medicine
- Vol. 2026 (1) , 9730076
Two Cases of Oculomotor Nerve Palsy in Idiopathic Intracranial Hypertension and a Literature Review
Idiopathic intracranial hypertension (IIH) is characterized by elevated intracranial pressure in the absence of a secondary cause. Classically, it presents with headache, visual obscurations, pulsatile tinnitus, and diplopia, most commonly due to abducens nerve palsy. Involvement of other cranial nerves is rare. We report two patients with oculomotor nerve palsy in the setting of IIH. The first, a 26‐year‐old woman with a body mass index (BMI) of 35 kg/m 2 , had a unilateral complete oculomotor nerve palsy, with imaging supportive of IIH and lumbar puncture opening pressure > 55 cmH 2 O. The second, a 19‐year‐old man with a BMI of 38.5 kg/m 2 , had a unilateral partial oculomotor nerve palsy, bilateral abduction paresis, and left‐sided tongue dysgeusia, with imaging supportive of IIH and opening pressure of 36 cmH 2 O. Both demonstrated marked symptomatic improvement on acetazolamide. Including the patients initially presented here, a literature review identified 21 documented cases of oculomotor nerve palsy associated with apparent IIH. Of these, 13 satisfied contemporary or historic diagnostic criteria for IIH. These cases underscore the rarity of this manifestation and the importance of recognizing IIH as a potential cause of oculomotor nerve palsy to ensure timely diagnosis and management and to prevent irreversible vision loss.
- 1 January 2026
- Published by Wiley in Case Reports in Neurological Medicine
- Vol. 2026 (1) , 9730076
Open AccessTwo Cases of Oculomotor Nerve Palsy in Idiopathic Intracranial Hypertension and a Literature Review
Idiopathic intracranial hypertension (IIH) is characterized by elevated intracranial pressure in the absence of a secondary cause. Classically, it presents with headache, visual obscurations, pulsatile tinnitus, and diplopia, most commonly due to abducens nerve palsy. Involvement of other cranial nerves is rare. We report two patients with oculomotor nerve palsy in the setting of IIH. The first, a 26‐year‐old woman with a body mass index (BMI) of 35 kg/m 2 , had a unilateral complete oculomotor nerve palsy, with imaging supportive of IIH and lumbar puncture opening pressure > 55 cmH 2 O. The second, a 19‐year‐old man with a BMI of 38.5 kg/m 2 , had a unilateral partial oculomotor nerve palsy, bilateral abduction paresis, and left‐sided tongue dysgeusia, with imaging supportive of IIH and opening pressure of 36 cmH 2 O. Both demonstrated marked symptomatic improvement on acetazolamide. Including the patients initially presented here, a literature review identified 21 documented cases of oculomotor nerve palsy associated with apparent IIH. Of these, 13 satisfied contemporary or historic diagnostic criteria for IIH. These cases underscore the rarity of this manifestation and the importance of recognizing IIH as a potential cause of oculomotor nerve palsy to ensure timely diagnosis and management and to prevent irreversible vision loss.
- Open Access
- 10 December 2024
- Published by Oxford University Press (OUP) in ATS Scholar
- Vol. 6 (1) , 109-110
Sleep Disturbances in Chronic Pain
- 10 December 2024
- Published by Oxford University Press (OUP) in ATS Scholar
- Vol. 6 (1) , 109-110
Open AccessSleep Disturbances in Chronic Pain
- 29 May 2024
- Published by Elsevier in World Neurosurgery
- Vol. 188, e491-e496
High Rate of Angiogram-Negative Subarachnoid Hemorrhage in a Rural Population: Role of Venous Drainage
- 29 May 2024
- Published by Elsevier in World Neurosurgery
- Vol. 188, e491-e496
High Rate of Angiogram-Negative Subarachnoid Hemorrhage in a Rural Population: Role of Venous Drainage
- Open Access
- 2 November 2023
- Published by Oxford University Press (OUP) in ATS Scholar
- Vol. 5 (1) , 218-219
Stroke and Obstructive Sleep Apnea: What Patients Need to Know
- 2 November 2023
- Published by Oxford University Press (OUP) in ATS Scholar
- Vol. 5 (1) , 218-219
Open AccessStroke and Obstructive Sleep Apnea: What Patients Need to Know
- 1 November 2023
- Published by Wolters Kluwer Health in Stroke: Vascular and Interventional Neurology
- Vol. 3 (S2)
Abstract 084: Intracranial Onyx Resolute Stenting In Idiopathic Intracranial Hypertension Patient With Pre‐existing Nickel Allergy: Case Report
Introduction: Idiopathic intracranial hypertension (IIH) is a pathology involving an increase in intracranial pressure leading to symptoms including papilledema, tinnitus, and elevated cerebrospinal fluid opening pressure. Recent research has identified venous sinus stenosis as a cause of IIH, a common treatment of which is venous stenting and angioplasty. An adverse event of this procedure is in‐stent stenosis (ISS), due to either neointimal hyperplasia or hypersensitivity to an element in the stent. There has been speculation regarding whether nickel in intracranial stents is a cause of concern, due to its potential to cause a Type IV hypersensitivity reaction and ISS, which is an indicator of future stroke. The purpose of this case report is to determine if the cobalt‐based alloy Onyx Resolute intracranial stents can safely treat IIH in patients with allergic contact dermatitis to nickel. Methods: We present a 38‐year old woman who presented with migraines and IIH with papilledema and severe pulsatile tinnitus. Headaches had been present for 5‐10 years. Ophthalmology consult revealed bilateral papilledema, upon which an MRI and MRV revealed venous stenosis. There was a 17mmHg pressure gradient measured in the patient. Patient could not tolerate acetazolamide, with kidney stones and loss of sheen in hair. Cerebral angiogram indicated right transverse‐sigmoid junction stenosis and atretic left venous sinus. The patient had an Onyx Resolute stent placed in the right transverse sigmoid junction. The Onyx Resolute stent is a Zotarolimus‐eluting stent made up of a cobalt‐based shell and a platinum‐Iridium core and is not recommended for patients with a hypersensitivity to nickel, cobalt, or chromium, but has a lower nickel content than a self‐expanding stent. Results: Patient underwent cerebral angiogram, revealing right transverse‐sigmoid junction stenosis with a 17mmHg pressure gradient. Stenting and angioplasty were performed; this reduced the venous sinus pressure in the R transverse sinus (pre‐stenotic segment) from 43 mm Hg to 24 mm Hg with resolution of the R transverse‐sigmoid junction pressure gradient. Patient was treated with prasugrel (Effient) for one month. At the one‐month follow‐up, the patient reported an improvement of symptoms, with near‐resolution of her prior headaches in terms of severity and frequency following her procedure. Visual acuity is at baseline, pending formal follow‐up assessment for papilledema. Follow‐up CT Head Venogram with and without contrast showed a patent R transverse to sigmoid venous stent. The patient was continued on aspirin 81mg daily and prasugrel 5mg daily and is to continue follow‐up with yearly ophthalmologic exams. Conclusion: Although there is speculation regarding the use of metal intracranial stents in patients allergic to nickel, our patient has shown that it is safe to use the Onyx Resolute intracranial stent despite a pre‐existing nickel hypersensitivity.
- 1 November 2023
- Published by Wolters Kluwer Health in Stroke: Vascular and Interventional Neurology
- Vol. 3 (S2)
Abstract 084: Intracranial Onyx Resolute Stenting In Idiopathic Intracranial Hypertension Patient With Pre‐existing Nickel Allergy: Case Report
Introduction: Idiopathic intracranial hypertension (IIH) is a pathology involving an increase in intracranial pressure leading to symptoms including papilledema, tinnitus, and elevated cerebrospinal fluid opening pressure. Recent research has identified venous sinus stenosis as a cause of IIH, a common treatment of which is venous stenting and angioplasty. An adverse event of this procedure is in‐stent stenosis (ISS), due to either neointimal hyperplasia or hypersensitivity to an element in the stent. There has been speculation regarding whether nickel in intracranial stents is a cause of concern, due to its potential to cause a Type IV hypersensitivity reaction and ISS, which is an indicator of future stroke. The purpose of this case report is to determine if the cobalt‐based alloy Onyx Resolute intracranial stents can safely treat IIH in patients with allergic contact dermatitis to nickel. Methods: We present a 38‐year old woman who presented with migraines and IIH with papilledema and severe pulsatile tinnitus. Headaches had been present for 5‐10 years. Ophthalmology consult revealed bilateral papilledema, upon which an MRI and MRV revealed venous stenosis. There was a 17mmHg pressure gradient measured in the patient. Patient could not tolerate acetazolamide, with kidney stones and loss of sheen in hair. Cerebral angiogram indicated right transverse‐sigmoid junction stenosis and atretic left venous sinus. The patient had an Onyx Resolute stent placed in the right transverse sigmoid junction. The Onyx Resolute stent is a Zotarolimus‐eluting stent made up of a cobalt‐based shell and a platinum‐Iridium core and is not recommended for patients with a hypersensitivity to nickel, cobalt, or chromium, but has a lower nickel content than a self‐expanding stent. Results: Patient underwent cerebral angiogram, revealing right transverse‐sigmoid junction stenosis with a 17mmHg pressure gradient. Stenting and angioplasty were performed; this reduced the venous sinus pressure in the R transverse sinus (pre‐stenotic segment) from 43 mm Hg to 24 mm Hg with resolution of the R transverse‐sigmoid junction pressure gradient. Patient was treated with prasugrel (Effient) for one month. At the one‐month follow‐up, the patient reported an improvement of symptoms, with near‐resolution of her prior headaches in terms of severity and frequency following her procedure. Visual acuity is at baseline, pending formal follow‐up assessment for papilledema. Follow‐up CT Head Venogram with and without contrast showed a patent R transverse to sigmoid venous stent. The patient was continued on aspirin 81mg daily and prasugrel 5mg daily and is to continue follow‐up with yearly ophthalmologic exams. Conclusion: Although there is speculation regarding the use of metal intracranial stents in patients allergic to nickel, our patient has shown that it is safe to use the Onyx Resolute intracranial stent despite a pre‐existing nickel hypersensitivity.
- Open Access
Performance of RAPID noncontrast CT stroke platform in large vessel occlusion and intracranial hemorrhage detection
Background: Noncontrast CT (NCCT) is used to evaluate for intracerebral hemorrhage (ICH) and ischemia in acute ischemic stroke (AIS). Large vessel occlusions (LVOs) are a major cause of AIS, but challenging to detect on NCCT. Aims: The purpose of this study is to evaluate an AI software called RAPID NCCT Stroke (RAPID, iSchemaView, Menlo Park, CA) for ICH and LVO detection compared to expert readers. Methods: In this IRB approved retrospective, multicenter study, stand-alone performance of the software was assessed based on the consensus of 3 neuroradiologists and sensitivity and specificity were determined. The platform’s performance was then compared to interpretation by readers comprised of eight general radiologists (GR) and three neuroradiologists (NR) in detecting ICH and hyperdense vessel sign (HVS) indicating LVO. Receiver operating characteristics (ROC) curve was used to evaluate the performance of each reader. P < 0.05 was considered significant. Results: A total of 244 cases were included. Of the 244, 115 were LVOs and 26 were ICHs. One hundred three cases did not have LVO nor ICH. Stand-alone performance of the software demonstrated sensitivities and specificities of 96.2% and 99.5% for ICH and 63.5% and 95.1% for LVO detection. Compared to all 11 readers and eight GR readers only respectively, the software demonstrated superiority, achieving significantly higher sensitivities (63.5% versus 43.6%, p < 0.0001 and 63.5% versus 40.9%, p =0.001). Conclusion: The RAPID NCCT Stroke platform demonstrates superior performance to radiologists for detecting LVO from a NCCT. Use of this software platform could lead to earlier LVO detection and expedited transfer of these patients to a thrombectomy capable center.
Open AccessPerformance of RAPID noncontrast CT stroke platform in large vessel occlusion and intracranial hemorrhage detection
Background: Noncontrast CT (NCCT) is used to evaluate for intracerebral hemorrhage (ICH) and ischemia in acute ischemic stroke (AIS). Large vessel occlusions (LVOs) are a major cause of AIS, but challenging to detect on NCCT. Aims: The purpose of this study is to evaluate an AI software called RAPID NCCT Stroke (RAPID, iSchemaView, Menlo Park, CA) for ICH and LVO detection compared to expert readers. Methods: In this IRB approved retrospective, multicenter study, stand-alone performance of the software was assessed based on the consensus of 3 neuroradiologists and sensitivity and specificity were determined. The platform’s performance was then compared to interpretation by readers comprised of eight general radiologists (GR) and three neuroradiologists (NR) in detecting ICH and hyperdense vessel sign (HVS) indicating LVO. Receiver operating characteristics (ROC) curve was used to evaluate the performance of each reader. P < 0.05 was considered significant. Results: A total of 244 cases were included. Of the 244, 115 were LVOs and 26 were ICHs. One hundred three cases did not have LVO nor ICH. Stand-alone performance of the software demonstrated sensitivities and specificities of 96.2% and 99.5% for ICH and 63.5% and 95.1% for LVO detection. Compared to all 11 readers and eight GR readers only respectively, the software demonstrated superiority, achieving significantly higher sensitivities (63.5% versus 43.6%, p < 0.0001 and 63.5% versus 40.9%, p =0.001). Conclusion: The RAPID NCCT Stroke platform demonstrates superior performance to radiologists for detecting LVO from a NCCT. Use of this software platform could lead to earlier LVO detection and expedited transfer of these patients to a thrombectomy capable center.
- Top Cited Papers
- 1 January 2019
- Published by Elsevier in The Lancet Neurology
- Vol. 18 (1) , 46-55
Penumbral imaging and functional outcome in patients with anterior circulation ischaemic stroke treated with endovascular thrombectomy versus medical therapy: a meta-analysis of individual patient-level data
- 1 January 2019
- Published by Elsevier in The Lancet Neurology
- Vol. 18 (1) , 46-55
Top Cited PapersPenumbral imaging and functional outcome in patients with anterior circulation ischaemic stroke treated with endovascular thrombectomy versus medical therapy: a meta-analysis of individual patient-level data
- Top Cited Papers
- 1 October 2018
- Published by Elsevier in The Lancet Neurology
- Vol. 17 (10) , 895-904
Imaging features and safety and efficacy of endovascular stroke treatment: a meta-analysis of individual patient-level data
- 1 October 2018
- Published by Elsevier in The Lancet Neurology
- Vol. 17 (10) , 895-904
Top Cited PapersImaging features and safety and efficacy of endovascular stroke treatment: a meta-analysis of individual patient-level data
- Top Cited PapersOpen Access
- 1 January 2018
- Published by Elsevier in The Lancet Neurology
- Vol. 17 (1) , 47-53
Effect of general anaesthesia on functional outcome in patients with anterior circulation ischaemic stroke having endovascular thrombectomy versus standard care: a meta-analysis of individual patient data
- 1 January 2018
- Published by Elsevier in The Lancet Neurology
- Vol. 17 (1) , 47-53
Top Cited PapersOpen AccessEffect of general anaesthesia on functional outcome in patients with anterior circulation ischaemic stroke having endovascular thrombectomy versus standard care: a meta-analysis of individual patient data